| LncRNA | MiRNA | Gene | Gene name | Pathway Name | Description | Title | Disease/Tissue | Journal | PubMed ID |
| CCAT1 | miR-181a | CPEB2 | CPEB2CPE-BP2；CPEB-2；hCPEB-2 | details | details
Taken together, lncRNA CCAT1 regulates the sensitivity of paclitaxel in NPC cells via miR-181a/CPEB2 axis.
|
details
LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis
|
Nasopharynx Cancer | Cell Cycle | 28358263 |
| TUG1 | miR-186 | CPEB2 | CPEB2；CPE-BP2；CPEB-2；hCPEB-2 | details | details
Furthermore, bioinformatics analysis showed that miR-186 could directly bind to TUG1, suggesting TUG1 might worked as a ceRNA to sponge miR-186. Extensively, our study also showed that CPEB2 was the direct target of miR-186 in colorectal cancer cells. Taken together, our study suggests that lncRNA TUG1 mediates MTX resistance in colorectal cancer via miR-186/CPEB2 axis.
|
details
TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis
|
Colorectal Cancer | Biochem Biophys Res Commun | 28302487 |
| TUG1 | miR-186 | CPEB2 | CPEB2CPE-BP2；CPEB-2；hCPEB-2 | details | details
Furthermore, bioinformatics analysis showed that miR-186 could directly bind to TUG1, suggesting TUG1 might worked as a ceRNA to sponge miR-186. Extensively, our study also showed that CPEB2 was the direct target of miR-186 in colorectal cancer cells. Taken together, our study suggests that lncRNA TUG1 mediates MTX resistance in colorectal cancer via miR-186/CPEB2 axis.
|
details
TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis.
|
Colorectal cancer | Biochem Biophys Res Commun | 28302487 |